S Kasper

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia
    Siegfried Kasper
    Medical University of Vienna, Department of General Psychiatry, Vienna, Austria
    Depress Anxiety 20:44-7. 2004
  2. ncbi Reboxetine: the first selective noradrenaline re-uptake inhibitor
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Expert Opin Pharmacother 1:771-82. 2000
  3. ncbi Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin
    S Kasper
    Department of General Psychiatry, University of Vienna, Hospital for Psychiatry, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 12:119-22. 2002
  4. ncbi Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Psychopharmacology (Berl) 159:445-6. 2002
  5. ncbi Quetiapine: efficacy and tolerability in schizophrenia
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 11:S405-13. 2001
  6. ncbi Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Neuropsychopharmacol 11:307-21. 2001
  7. ncbi Hypericum perforatum--a review of clinical studies
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Pharmacopsychiatry 34:S51-5. 2001
  8. ncbi Cognitive effects and antipsychotic treatment
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Psychoneuroendocrinology 28:27-38. 2003
  9. ncbi Zotepine in the treatment of acute hospitalized schizophrenic episodes
    S Kasper
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien, Austria
    Int Clin Psychopharmacol 16:163-8. 2001
  10. ncbi Intravenous antidepressant treatment: focus on citalopram
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Wien, Austria
    Eur Arch Psychiatry Clin Neurosci 252:105-9. 2002

Collaborators

Detail Information

Publications130 found, 100 shown here

  1. ncbi Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia
    Siegfried Kasper
    Medical University of Vienna, Department of General Psychiatry, Vienna, Austria
    Depress Anxiety 20:44-7. 2004
    ..13 (-1.23, -1.04) and after 156 weeks, it was -1.33 (-1.78, -0.87). Therefore, the efficacy of quetiapine for the treatment of anxiety and depressive symptoms is maintained in long-term treatment...
  2. ncbi Reboxetine: the first selective noradrenaline re-uptake inhibitor
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Expert Opin Pharmacother 1:771-82. 2000
    ..The availability of reboxetine represents a significant addition to the currently available pharmacologic armamentarium for the treatment of depression...
  3. ncbi Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin
    S Kasper
    Department of General Psychiatry, University of Vienna, Hospital for Psychiatry, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 12:119-22. 2002
    ..Concomitant treatment with tamsulosin should be considered for those patients in whom urinary hesitancy may lead to withdrawal from reboxetine therapy...
  4. ncbi Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Psychopharmacology (Berl) 159:445-6. 2002
  5. ncbi Quetiapine: efficacy and tolerability in schizophrenia
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 11:S405-13. 2001
    ....
  6. ncbi Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Neuropsychopharmacol 11:307-21. 2001
    ....
  7. ncbi Hypericum perforatum--a review of clinical studies
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Pharmacopsychiatry 34:S51-5. 2001
    ..John's wort preparations comprise patients with mild or moderate depression. Based on the existing literature, limitations to efficacy in more severe cases as well as interactions and contraindications have to be respected...
  8. ncbi Cognitive effects and antipsychotic treatment
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Psychoneuroendocrinology 28:27-38. 2003
    ....
  9. ncbi Zotepine in the treatment of acute hospitalized schizophrenic episodes
    S Kasper
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien, Austria
    Int Clin Psychopharmacol 16:163-8. 2001
    ..Zotepine improved both positive and negative symptoms and was not accompanied by extrapyramidal side-effects, justifying its classification as an atypical antipsychotic...
  10. ncbi Intravenous antidepressant treatment: focus on citalopram
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Wien, Austria
    Eur Arch Psychiatry Clin Neurosci 252:105-9. 2002
    ..The aim of this paper is to review available data detailing the clinical outcome of intravenously administered citalopram in depressed patients...
  11. ncbi Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials
    S Kasper
    Department of General Psychiatry, University of Vienna, Wien, Austria
    Psychopharmacology (Berl) 164:301-8. 2002
    ..Although extracts from Hypericum have long played a major role in the treatment of mild to moderate depression, information pertaining to the drug's therapeutic profile is sparse...
  12. ncbi Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology
    Siegfried Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    World J Biol Psychiatry 3:133-46. 2002
    ..Our data provide insight into the pathophysiology of neuropsychiatric disorders and may guide future psychopharmacological drug developments...
  13. ncbi A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression
    S Kasper
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Psychiatry 17:331-40. 2002
    ..07 depending on the methodology) was found in favor of tianeptine. All in all, this study confirmed that tianeptine is at least as effective as SSRI, with a trend for a better acceptability profile in the treatment of depressed patients...
  14. ncbi Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia
    Siegfried Kasper
    Department of General Psychiatry, University of Vienna, Vienna, Austria
    Int Clin Psychopharmacol 17:S19-26. 2002
    ....
  15. ncbi Atypical antipsychotics in mood disorders
    Siegfried Kasper
    Department of General Psychiatry, University of Vienna, Vienna, Austria
    Int Clin Psychopharmacol 17:S1-10. 2002
    ....
  16. ncbi No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism
    M Willeit
    Department of General Psychiatry, Vienna University, Vienna, Austria
    Biol Psychiatry 50:8-12. 2001
    ..CONCLUSIONS: Our data provide no evidence for in vivo functional regulation of 5-HTT availability by 5-HTTLPR in the thalamus-hypothalamus and mesencephalon-pons of healthy subjects...
  17. ncbi In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol
    J Tauscher
    Department of General Psychiatry, University of Vienna, Austria
    Psychopharmacology (Berl) 141:175-81. 1999
    ..No clinical relevant EPS occurred during treatment with olanzapine or clozapine. There was no correlation between the degree of striatal D2 receptor occupancy and clinical improvement...
  18. ncbi A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder
    M Willeit
    Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria
    Mol Psychiatry 8:942-6. 2003
    ..007). Our data are compatible with the hypothesis of a disease process that is not causally related to 5-HTTLPR, but involves 5-HT neurotransmission and 5-HTTLPR somewhere on its way to phenotypic disease expression...
  19. ncbi Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients
    J Scharfetter
    University Hospital for Psychiatry, Department for General Psychiatry, Vienna, Austria
    Eur Neuropsychopharmacol 10:17-20. 1999
    ..033) by this pharmacogenetic approach. A combined analysis with two previous studies (Shaikh et al., Hum. Genet. 97 (1996) 714-719; Malhotra et al., Mol. Psychiatry 3 (1998) 72-75) further substantiates these results (P=0.0041)...
  20. pmc Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
    R Lanzenberger
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Mol Psychiatry 18:93-100. 2013
    ..This PET study proposes a global involvement of the postsynaptic 5-HT(1A) receptor binding in the effect of ECT...
  21. ncbi Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls
    A Neumeister
    Department of General Psychiatry, University of Vienna, Austria
    Psychol Med 31:1467-73. 2001
    ..However, these findings provide evidence that brain dopaminergic systems may be involved in the pathophysiology of SAD...
  22. doi Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial
    S Kasper
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, Austria
    Eur Neuropsychopharmacol 18:803-13. 2008
    ..WS 5570 showed a beneficial effect in preventing relapse after recovery from acute depression. Tolerability in continuation and long-term maintenance treatment was on the placebo level...
  23. ncbi In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment
    J Tauscher
    Department of General Psychiatry, University Hospital of Vienna, Austria
    Eur Neuropsychopharmacol 9:177-9. 1999
    ..Four hours after injection of the tracer more than 40% of serotonin transporters were blocked. To our knowledge, this is the first direct documentation of the pharmacodynamic action of fluoxetine in the human brain in vivo...
  24. ncbi Association studies of candidate genes in bipolar disorders
    A Heiden
    Department of General Psychiatry, Vienna, Austria
    Neuropsychobiology 42:18-21. 2000
    ..No association between 5-HT2a, DRD2, DRD3, DAT1 and bipolar disorder was found...
  25. ncbi [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa
    J Tauscher
    Department of General Psychiatry, University of Vienna, Vienna, Austria
    Biol Psychiatry 49:326-32. 2001
    ....
  26. ncbi Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine
    J Tauscher
    Department of General Psychiatry, University of Vienna, Austria
    Psychopharmacology (Berl) 133:102-5. 1997
    ..This might be of importance for the design of clinical trials and brain imaging studies in the future...
  27. ncbi No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study
    M Stamenkovic
    Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 11:69-74. 2001
    ..The objective of our study was to measure DAT densities with [(123)I]-beta-CIT binding in TD patients who were either psychotropic drug naive or currently treated with antipsychotics (AP) and healthy controls...
  28. ncbi In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients
    C Barnas
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Psychopharmacology (Berl) 157:236-42. 2001
    ..Single photon emission computed tomography (SPECT) using (123)I iodobenzamide (IBZM) as tracer substance has been shown to be a useful tool to visualize dopamine 2 (D2) receptor occupancy...
  29. ncbi Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder
    N Praschak-Rieder
    Department of General Psychiatry, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Affect Disord 63:239-42. 2001
    ..In the present study we compared the point prevalence rates of PMDD between a sample of premenopausal female patients suffering from SAD and healthy female controls...
  30. ncbi Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation
    A Neumeister
    Department of General Psychiatry, Vienna University, Austria
    Arch Gen Psychiatry 55:167-72. 1998
    ..We investigated the effects of short-term tryptophan depletion (TD) on depressed patients who responded to a single night of total SD...
  31. ncbi Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy
    A Neumeister
    Department of General Psychiatry, Vienna University, Austria
    Arch Gen Psychiatry 54:133-8. 1997
    ..Light therapy-induced remission from depression may be associated with changes in brain serotonin function...
  32. doi Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders
    C Spindelegger
    Department of Psychiatry and Psychotherapy, Medical University Vienna, Vienna, Austria
    Mol Psychiatry 14:1040-50. 2009
    ..034). The significance of the hippocampus region survived the Bonferroni-adjusted threshold for multiple comparisons. These PET data in humans in vivo demonstrate a reduction of the 5-HT(1A) binding potential after SSRI treatment...
  33. ncbi Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample
    D Winkler
    Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Eur Arch Psychiatry Clin Neurosci 252:54-62. 2002
    ....
  34. ncbi The citalopram challenge test in patients with major depression and in healthy controls
    T Kapitany
    Department of General Psychiatry, University of Vienna, Austria
    Psychiatry Res 88:75-88. 1999
    ..In conclusion, the 20-mg citalopram challenge test is thought to be a promising tool for further investigation of serotonergic function in psychiatric illness...
  35. ncbi Different fatal toxicity of neuroleptics identified by autopsy
    D Schreinzer
    Department of General Psychiatry, University Hospital of Psychiatry, A 1090, Vienna, Austria
    Eur Neuropsychopharmacol 11:117-24. 2001
    ..We are not aware of the psychiatric diagnoses in our post-mortem sample. However, the present results indicate that careless use of low-potent NLs should be avoided in patients with a potential risk of accidental or suicidal overdose...
  36. ncbi Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy
    A Heiden
    Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria
    Psychiatry Res 89:239-46. 1999
    ..Mg i.v. may be a useful supplementary therapy for the clinical management of severe manic agitation. This open study needs double-blind confirmation...
  37. doi Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers
    R M Kaufmann
    Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Pharmacopsychiatry 43:24-32. 2010
    ..With respect to acute psychotropic effects, the aim of this study is the comparison of an oral cannabis extract and low-dose diazepam in a cross-over experiment in drug-naïve healthy women...
  38. ncbi Non-association of dopamine D4 and D2 receptor genes with personality in healthy individuals
    C Gebhardt
    Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria
    Psychiatr Genet 10:131-7. 2000
    ..The present results therefore do not provide evidence that the DRD2 and DRD4 receptor genes contribute a common and relevant effect to personality traits...
  39. ncbi Escitalopram in seasonal affective disorder: results of an open trial
    E Pjrek
    Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
    Pharmacopsychiatry 40:20-4. 2007
    ..The aim of this study was to evaluate the efficacy and tolerability of escitalopram in the treatment of seasonal affective disorder (SAD, fall-winter depression)...
  40. ncbi Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
    S Kasper
    Department of General Psychiatry, University of Vienna, Wien, Austria
    Eur Arch Psychiatry Clin Neurosci 249:83-9. 1999
    ..g. 5-HT1A) will further shed light on the pathophysiology of schizophrenia as well as possible psychopharmacological treatment perspectives...
  41. ncbi Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design
    S Kasper
    Department of General Psychiatry, Medical University of Vienna, Austria
    Int J Methods Psychiatr Res 13:176-83. 2004
    ..Notably, it includes long-term prophylactic treatment with the same drug and the same therapeutic dose applied during acute treatment, uses well-defined outcome measures and provides a clear distinction between relapse and recurrence...
  42. ncbi [Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999]
    M Letmaier
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien, Austria
    Nervenarzt 75:249-57. 2004
    ....
  43. ncbi Fluoxetine treatment in patients with recurrent brief depression
    M Stamenkovic
    Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
    Int Clin Psychopharmacol 16:221-6. 2001
    ..Our study shows the effectiveness of fluoxetine in this depressive disorder. To confirm these preliminary results, a double-blind controlled study is necessary...
  44. ncbi [Therapeutic sleep deprivation and phototherapy]
    N Praschak-Rieder
    Klinischen Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien
    Wien Med Wochenschr 149:520-4. 1999
    ..Bright light therapy, beginning in the morning after partial sleep deprivation, is able to prevent the depressive relapse after the next night of sleep in sleep deprivation responders...
  45. ncbi Occurrence of mirtazapine-induced delirium in organic brain disorder
    U Bailer
    Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria
    Int Clin Psychopharmacol 15:239-43. 2000
    ..One possible hypothesis for the observed deliria is a central increase of norepinephrine after acute administration of mirtazapine. Subclinical brain disease might have favoured the occurrence of delirium in the three cases...
  46. ncbi [Use of electroconvulsive therapy in psychiatry]
    R Frey
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wahringer Gurtel 18 20, A 1090 Wien
    Nervenarzt 72:661-76. 2001
    ..There is a need for controlled studies on continuation therapy subsequent to successful ECT...
  47. ncbi Topiramate as a mood stabilizer
    M Letmaier
    Department of General Psychiatry, University of Vienna, Austria
    Int Clin Psychopharmacol 16:295-8. 2001
    ..The patient, now on 200 mg/day, is mostly asymptomatic and has functioned well for over 17 months, in contrast to 13 hospitalizations during the previous 10 years...
  48. doi [The effects of hormone replacement therapy on mind and brain]
    P Baldinger
    Universitatsklinik fur Psychiatrie und Psychotherapie, Medizinische Universität Wien, Wahringer Gurtel 18 20, 1090 Wien, Osterreich
    Nervenarzt 84:14-9. 2013
    ..The interactions between estrogen, progesterone and the serotonergic system are described, and possible neurobiological and endocrinological mechanisms underlying depressive symptoms in the perimenopause are elucidated...
  49. ncbi [Depression and anxiety]
    S Kasper
    Klinischen Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien
    Wien Med Wochenschr 149:494-502. 1999
    ..Reviewed topics should make easy recognition and therapy possible for the general practitioner...
  50. ncbi Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials
    S Kasper
    Department of Psychiatry und Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, Vienna, 1090, Austria
    Eur Arch Psychiatry Clin Neurosci 258:59-63. 2008
    ..The analysis shows that St. John's wort extract WS 5570 has a meaningful beneficial effect during acute treatment of patients suffering from mild depression and leads to a substantial increase in the probability of remission...
  51. ncbi No association of clock gene T3111C polymorphism and affective disorders
    U Bailer
    Department of General Psychiatry, University Hospital for Psychiatry, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur Neuropsychopharmacol 15:51-5. 2005
    ..Data of our sample replicate prior findings of Desan et al. [Am. J. Med. Genet. 12 (2000) 418]. Subsamples of patients with high numbers of affective episodes did show some deviations in genotypes (p=0.0585)...
  52. ncbi Study of family history in seasonal affective disorder
    M Stamenkovic
    Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
    Neuropsychobiology 44:65-9. 2001
    ....
  53. ncbi Reboxetine in seasonal affective disorder: an open trial
    E Hilger
    Department of General Psychiatry, University of Vienna Waehringer Guertel 18-20 A-1090 Vienna, Austria
    Eur Neuropsychopharmacol 11:1-5. 2001
    ..In conclusion, our preliminary results are in line with evidence from recent studies suggesting that catecholaminergic systems might also be involved in the pathophysiology of SAD...
  54. doi Treatment of seasonal affective disorder with duloxetine: an open-label study
    E Pjrek
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Pharmacopsychiatry 41:100-5. 2008
    ..The aim of this observational study was to evaluate the effects of duloxetine in the treatment of seasonal affective disorder (SAD)...
  55. ncbi Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine
    C Vesely
    Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
    Int Clin Psychopharmacol 15:57-60. 2000
    ..Over the same period, dopamine D2 receptor occupancy decreased substantially, as measured by IBZM-SPECT after 14 and 77 days of treatment...
  56. ncbi [Pharmacotherapy of seasonal depression]
    E Hilger
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wahringer Gurtel 18 20, A 1090 Wien
    Nervenarzt 73:22-9; quiz 30-1. 2002
    ..There is, however, a clear need for further placebo-controlled studies to evaluate pharmacological treatment options for SAD...
  57. ncbi [Diagnosis and therapy of eating disorders]
    U Bailer
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien, Osterreich
    Wien Klin Wochenschr 112:865-75. 2000
    ..The paper also deals with medical complications of eating disorders, motivational interviewing in anorexia nervosa and treatment with self-help manuals in bulimia nervosa...
  58. doi Mortality and employment after in-patient opiate detoxification
    A Naderi-Heiden
    Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur Psychiatry 27:294-300. 2012
    ..We considered that completed opiate detoxification resulted in increased life expectancy and earning capacity as compared to non-completed detoxification...
  59. ncbi Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements
    L M Pezawas
    Clinical Department of General Psychiatry, University Hospital for Psychiatry, University of Vienna, Wien, Austria
    Psychiatry Res 83:139-47. 1998
    ....
  60. ncbi Quetiapine in combination with citalopram in patients with unipolar psychotic depression
    A Konstantinidis
    Department of General Psychiatry, Medical University Vienna, Austria
    Prog Neuropsychopharmacol Biol Psychiatry 31:242-7. 2007
    ..Further studies of larger, double-blind, parallel-group design are warranted to confirm these findings...
  61. ncbi Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults
    L Pezawas
    Department of General Psychiatry, University of Vienna, Austria
    Psychol Med 33:407-18. 2003
    ....
  62. ncbi Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder?
    A Neumeister
    Department of General Psychiatry, Vienna University, Austria
    Int Clin Psychopharmacol 14:313-5. 1999
    ....
  63. ncbi Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Int Clin Psychopharmacol 16:189-96. 2001
    ..6 +/- 2.9). These findings were very consistent across all nine countries. The results from RODOS suggest that treatment costs are significantly higher with olanzapine than with risperidone without any clinical benefit to offset this...
  64. ncbi Inverse relation between stimulus intensity and seizure duration: implications for ECT procedure
    R Frey
    Department of General Psychiatry, University Hospital of Psychiatry, University of Vienna, Austria
    J ECT 17:102-8. 2001
    ..Furthermore, focus on seizure duration led to frequent high-dose restimulation in the elderly. The titration method obviates inadequate or excessive charges because the seizure threshold must first be determined...
  65. doi Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program
    A Konstantinidis
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Int J Neuropsychopharmacol 15:449-57. 2012
    ..However, this effect was not only due to augmentation strategies for severely depressed inpatients. Further studies are needed to examine possible putative effects of AP augmentation treatment in mild to moderate depression...
  66. ncbi Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study
    S Kasper
    Department of General Psychiatry, University of Vienna, Austria
    Int Clin Psychopharmacol 16:179-87. 2001
    ..In conclusion, the clinical outcomes reported by RODOS suggest that risperidone may be more effective as a first-line therapy drug for schizophrenia than olanzapine...
  67. doi Intensive care in psychiatry
    D Winkler
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Eur Psychiatry 26:260-4. 2011
    ..Furthermore, we present diagnoses, diagnostic procedures and specific treatments of a sample of 100 consecutive inpatients treated in the years 2008 and 2009 at this ward...
  68. ncbi Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia
    S Kasper
    Department of General Psychiatry, University of Vienna, Wien, Austria
    Int Clin Psychopharmacol 13:253-62. 1998
    ..Knowledge gained through clinical experience is needed to augment clinical trial results and to help define the most effective use of each of these agents...
  69. ncbi Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy
    A Neumeister
    National Institute of Mental Health, Clinical Psychobiology Branch, Bethesda, MD, USA
    Arch Gen Psychiatry 55:524-30. 1998
    ..Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored...
  70. ncbi Intravenous mirtazapine in the treatment of depressed inpatients
    A Konstantinidis
    Department of General Psychiatry, University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Eur Neuropsychopharmacol 12:57-60. 2002
    ..001). Side effects were mild and transient. Altogether, the results of this preliminary study show that intravenous mirtazapine is an effective, safe and well tolerated treatment for depressed inpatients...
  71. ncbi Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers
    J Tauscher
    Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Am J Psychiatry 158:1326-8. 2001
    ..The authors investigated the relationship between anxiety--a facet of the Revised NEO Personality Inventory dimension of neuroticism--and serotonin 5-HT(1A) receptor binding potential...
  72. ncbi Monoamine depletion in non-pharmacological treatments for depression
    A Neumeister
    Department of General Psychiatry, Vienna University
    Adv Exp Med Biol 467:29-33. 1999
    ..Interestingly, tryptophan depletion prevented the relapse after the recovery night, possibly by enhancing brain serotonin transmission after the depletion procedure...
  73. ncbi [Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy]
    L Pezawas
    Abteilung für Allgemeine Psychiatrie, Universitätskliniken Wien, Wahringer Gurtel 18 20, A 1090 Wien
    Nervenarzt 72:169-80. 2001
    ..Future treatment studies without the limitations of previous studies are clearly needed in the field of RBD...
  74. ncbi Comparison of buprenorphine and methadone maintenance in opiate addicts
    H Eder
    Department of General Psychiatry, University Hospital of Psychiatry, Wahringer Gurtel, Vienna, Austria
    Eur Addict Res 4:3-7. 1998
    ..However, buprenorphine is clearly effective in the more motivated subjects and further investigation in this subgroup is recommended...
  75. ncbi Prevalence and distribution of hepatitis C subtypes in patients with opioid dependence
    W Gombas
    Drug Addiction Out Patient Clinic, Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
    Eur Addict Res 6:198-204. 2000
    ....
  76. ncbi Successful treatment of recurrent brief depression with reboxetine -- a single case analysis
    L Pezawas
    Department of General Psychiatry, University of Vienna, Austria
    Pharmacopsychiatry 35:75-6. 2002
    ..Furthermore, successful treatment of RBD has been reported in a few patients with carbamazepine, nimodipine, and verapamil in controlled double-blind single-case analyses using a flexible cross-over design...
  77. ncbi [High dose St. John's wort extract as a phytogenic antidepressant]
    S Kasper
    Klinischen Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien
    Wien Med Wochenschr 149:191-6. 1999
    ..Recent pharmacological studies revealed that hypericum extracts have a similar mechanism of action like the selective serotonin reuptake inhibitors (SSRI), however, very likely to a smaller extent...
  78. ncbi [Fatal poisonings with antidepressive drugs and neuroleptics. Analysis of a correlation with prescriptions in Vienna 1991 to 1997]
    R Frey
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wahringer Gurtel 18 20, A 1090 Wien
    Nervenarzt 73:629-36. 2002
    ..The present study demonstrates that the prescription of TCA or TCNL involves a relatively high risk of fatal intoxication...
  79. ncbi Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial
    Duerten Kudla
    Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Eur Psychiatry 22:195-202. 2007
    ..Secondary objectives included quality of life, subjective well-being, tolerability, and safety...
  80. ncbi Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
    Siegfried Kasper
    Department of General Psychiatry, Medical University of Vienna, Austria
    Int Clin Psychopharmacol 21:105-10. 2006
    ....
  81. pmc Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]
    Siegfried Kasper
    Department of General Psychiatry, Vienna Medical University, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    BMC Med 4:14. 2006
    ..The aim of the current study was to assess the antidepressant efficacy and safety of Hypericum perforatum (St. John's wort) extract WS 5570 at doses of 600 mg/day in a single dose and 1200 mg/day in two doses...
  82. ncbi Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine
    Stuart A Montgomery
    Imperial College School of Medicine, London, UK
    J Clin Psychiatry 67:771-82. 2006
    ..The current study compared the efficacy and safety of pregabalin and venlafaxine in patients diagnosed with moderate to severe GAD...
  83. ncbi Reduced serotonin-1A receptor binding in social anxiety disorder
    Rupert R Lanzenberger
    Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:1081-9. 2007
    ..The objective of this study was to investigate 5-HT1A receptor binding potential (BP) in social anxiety disorder (SAD)...
  84. ncbi Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms
    Siegfried Kasper
    Department of Psychiatry, Medical University of Vienna, Austria
    Eur Neuropsychopharmacol 16:S135-41. 2006
    ....
  85. ncbi Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine
    Trawat Attarbaschi
    Department of General Psychiatry, Medical University Vienna, Vienna, Austria
    Eur Neuropsychopharmacol 17:102-7. 2007
    ..Although we did not find an increased vulnerability for acute EPS in bipolar patients receiving olanzapine at clinical relevant doses, this needs to be replicated with larger sample sizes...
  86. ncbi Serum lipid levels in seasonal affective disorder
    Edda Pjrek
    Dept of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Eur Arch Psychiatry Clin Neurosci 257:197-202. 2007
    ..56 +/- 0.96 mmol/l; p = 0.126). The results of this study support the idea that low cholesterol levels may be of pathogenetic importance in SAD. Further study in larger clinical samples is warranted to clarify our findings...
  87. ncbi Escitalopram in the long-term treatment of major depressive disorder in elderly patients
    Siegfried Kasper
    Medical University of Vienna, Vienna, Austria
    Neuropsychobiology 54:152-9. 2006
    ..The secondary aim was to examine response to treatment, as measured by change in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from study entry to each visit, using observed cases...
  88. doi Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement
    Hans Jurgen Moller
    Department of Psychiatry, Ludwig Maximilians University Munchen, Nussbaumstrasse 7, 80336 Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 258:3-23. 2008
    ..It is the major problem facing efforts to identify the possible 'suicidal effects' of antidepressants...
  89. ncbi Do we need another atypical antipsychotic?
    Siegfried Kasper
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wein, Austria
    Eur Neuropsychopharmacol 18:S146-52. 2008
    ..The propensity of sertindole to cause anticholinergic effects, which can be particularly troublesome, is small and, more recently, there have been suggestions that sertindole may have beneficial effects on cognition...
  90. ncbi Escitalopram in the treatment of depressed elderly patients
    Siegfried Kasper
    Dept of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Am J Geriatr Psychiatry 13:884-91. 2005
    ..The authors examined the efficacy and tolerability of escitalopram and fluoxetine versus placebo in the treatment of elderly patients with major depressive disorder (MDD)...
  91. ncbi Season of birth in siblings of patients with seasonal affective disorder. A test of the parental conception habits hypothesis
    Edda Pjrek
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Eur Arch Psychiatry Clin Neurosci 257:378-82. 2007
    ..Further research could be conducted in non-seasonal depression as there is still a lack of studies on seasonality of birth in affective disorders...
  92. ncbi A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
    George I Papakostas
    Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WAC 812 Boston, MA 02114, USA
    Eur Neuropsychopharmacol 18:122-7. 2008
    ..These results suggest that the NRI reboxetine and the SSRIs differ with respect to their side-effect profile and overall tolerability but not their efficacy in treating MDD...
  93. ncbi Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
    Julia Sacher
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Neuropsychopharmacology 33:1633-41. 2008
    ..Our finding is suggestive that not all atypical antipsychotics cause acute direct effects on glucose disposal and that accurate determination of side effect profile should be performed when choosing an atypical antipsychotic...
  94. ncbi Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study
    Daniel Souery
    Department of Psychiatry, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium
    J Clin Psychiatry 68:1062-70. 2007
    ....
  95. ncbi Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
    Jean Pierre Olie
    Sainte Anne Hospital, University Department of Psychiatry, Paris, France
    Int J Neuropsychopharmacol 10:661-73. 2007
    ....
  96. ncbi Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria
    Dietmar Winkler
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Hum Psychopharmacol 22:245-51. 2007
    ..The aim of this observational study was to evaluate the effectiveness of escitalopram in a naturalistic sample of employed people with mood and anxiety disorders...
  97. ncbi Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
    Nikolas Klein
    Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Psychopharmacology (Berl) 191:333-9. 2007
    ..In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT)...
  98. ncbi Enhanced serotonin transporter function during depression in seasonal affective disorder
    Matthaus Willeit
    Department of Biological Psychiatry, Medical University of Vienna, Vienna, Austria
    Neuropsychopharmacology 33:1503-13. 2008
    ..5-HTTLPR was not associated with any of the 5-HTT parameters. In sum, we conclude that the 5-HTT is in a hyperfunctional state during depression in SAD and normalizes after light therapy and in natural summer remission...
  99. ncbi Treatment challenges in the acute hospital setting
    Siegfried Kasper
    World J Biol Psychiatry 6:210-1. 2005
  100. ncbi Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting
    Martin Letmaier
    Department of General Psychiatry, Medical University of Vienna, Austria
    Int J Neuropsychopharmacol 9:529-37. 2006
    ....
  101. ncbi [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease]
    Matthaus Willeit
    Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie Wien, Wien, Osterreich
    Wien Klin Wochenschr 115:281-90. 2003
    ..First-line evidence data on incidence, dimensions and outcome of cognitive side effects under maintenance electroconvulsive therapy is still warranted...